The Role of NRF2 in Obesity-Associated Cardiovascular Risk Factors
The raising prevalence of obesity is associated with an increased risk for cardiovascular diseases (CVDs), particularly coronary artery disease (CAD), and heart failure, including atrial fibrillation, ventricular arrhythmias and sudden death. Obesity contributes directly to incident cardiovascular r...
Main Authors: | Jorge Gutiérrez-Cuevas, Marina Galicia-Moreno, Hugo Christian Monroy-Ramírez, Ana Sandoval-Rodriguez, Jesús García-Bañuelos, Arturo Santos, Juan Armendariz-Borunda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-01-01
|
Series: | Antioxidants |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3921/11/2/235 |
Similar Items
-
Roles of Nrf2 in Liver Diseases: Molecular, Pharmacological, and Epigenetic Aspects
by: Marina Galicia-Moreno, et al.
Published: (2020-10-01) -
Molecular Mechanisms of Obesity-Linked Cardiac Dysfunction: An Up-Date on Current Knowledge
by: Jorge Gutiérrez-Cuevas, et al.
Published: (2021-03-01) -
Sulforaphane induced NRF2 activation in obese pregnancy attenuates developmental redox imbalance and improves early-life cardiovascular function in offspring
by: Paraskevi-Maria Psefteli, et al.
Published: (2023-11-01) -
Isoginkgetin, a bioactive constituent from Ginkgo Biloba, protects against obesity-induced cardiomyopathy via enhancing Nrf2/ARE signaling
by: Xiaoqian Wu, et al.
Published: (2022-11-01) -
Cardiovascular Biomarker Profiles in Obesity and Relation to Normalization of Subclinical Cardiac Dysfunction after Bariatric Surgery
by: Sanne M. Snelder, et al.
Published: (2022-01-01)